WW International, Inc. (WW) AI Stock Analysis

WW International, Inc. specializes in comprehensive weight management products and services worldwide. It operates across four segments: North America, Continental Europe, United Kingdom, and Other. The company provides nutritional, activity, behavioral, and lifestyle tools through personalized digital resources accessible via its mobile app and web-based platforms. These offerings include interactive digital subscription products and personal coaching. WW also fosters a member community and markets consumer items such as snack bars, cookbooks, and kitchen tools. In addition, the company licenses its trademarks and intellectual property for food, beverages, and consumer goods, distributing through e-commerce and retail partnerships.

WW International has experienced sustained top-line contraction, with annual revenue declining from $1.21B in FY2021 to $1.04B in FY2022, $889.6M in FY2023, $785.9M in FY2024, and $710.6M in FY2025. Despite revenue falling 9.6% in FY2025, gross margin expanded to 71.8%, up from 60.0% in FY2021. Operating margin was 6.5% in FY2025, down from 10.0% in FY2024. Net income swung to $1.06B in FY2025, though diluted EPS stood at -$5.51. In the latest quarter ending June 30, 2026, revenue fell 14.2% year-over-year, while quarterly earnings dropped 91.0% year-over-year. Operating margin over the trailing twelve months was 8.1% on revenue of $665.5M.

As of June 30, 2026, WW International held $101.5M in cash and short-term investments compared to $426.3M in total debt, resulting in net debt of $324.8M. Total assets were $840.4M against shareholders' equity of $278.6M, yielding a debt-to-equity ratio of 1.53 and a current ratio of 1.38. Operating cash flow was -$28.9M in FY2025, while free cash flow was -$46.4M after $17.5M in capital expenditures. Additionally, the company's share count increased 1219.6% over five years.

WW trades at a trailing price-to-earnings multiple of 0.1x and a forward P/E of 74.1x, compared to the median of its US-listed Healthcare peers of 24.6x trailing and 17.3x forward P/E. Its price-to-sales ratio stands at 0.2x versus the peer median of 4.1x, while its EV-to-EBITDA ratio is 0.3x compared to 12.0x for peers. Over the past year, the stock fell 55.4%, significantly lagging the S&P 500 (SPY) return of 16.8%. The stock last closed at $13.04, which is 23.0% below its 200-day moving average.

Four analysts cover WW International, with 2 Strong Buy ratings and 2 Hold ratings. The mean price target is $27.50, representing a 110.9% premium over the last close of $13.04. For the fiscal year ending December 31, 2026, consensus estimates project revenue of $630.8M and EPS of -$1.85. For the following fiscal year, three analysts forecast revenue of $634.7M and EPS of -$0.02. Over the last four quarters, the company beat EPS estimates twice. Its next earnings report is scheduled for November 5, 2026.

This page is an AI-written research summary of WW International, Inc. (WW). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: WW income statement, WW balance sheet, WW key metrics, WW analyst forecast, WW chart. See the WW stock overview for the latest quote and news.